Showing results (91-100 of 166) with videos related to
Sort By:
Pageof 17
Kidney International Reports|July 13, 2023
Describing Natural History and Exploring Risk Factors for Kidney Function Decline in Persons With CKD of Uncertain Etiology in Sri LankaPasan Hewavitharana, Stephen Schensul, Edison Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99Jakob R Passweg, Aristoteles A N Giagounidis, Mathew Simcock, et al.Oral Oncology|October 7, 2019
Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancerJoseph Zenga, Vasu Divi, Michael Stadler, et al.Rheumatology Advances in Practice|January 5, 2026
Patterns of steroid use in patients with established rheumatoid arthritis commencing treatment with biologic or targeted synthetic DMARDsMichael Stadler, Shae Bindra, Annie Cheung, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 28, 2017
Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell TransplantationJustyna Ogonek, Pavankumar Varanasi, Susanne Luther, et al.Leukemia Research|October 9, 2017
Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotypeLaura Hörster, Richard F Schlenk, Michael Stadler, et al.Transfusion|November 26, 2009
Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at riskDaphne Dahl, Andreas Hahn, Christian Koenecke, et al.Haematologica|March 16, 2012
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromesNorbert Gattermann, Carlo Finelli, Matteo Della Porta, et al.Cancer Chemotherapy and Pharmacology|November 19, 2015
First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70Taofeek Kunle Owonikoko, Arif Hussain, Walter Michael Stadler, et al.Scientific Reports|April 20, 2021
Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantationMartin W Hümmert, Michael Stadler, Lothar Hambach, et al.Pageof 17